Laurete, Mailyn N.

HRN: 16-15-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/09/2023
CEFUROXIME 1.5GM (VIAL)
06/09/2023
06/11/2023
IVTT
1.5g
Q8H
PROM
Waiting Final Action 
06/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/09/2023
06/11/2023
IVTT
500mg
Q8H
PROM
Waiting Final Action 
06/10/2023
CEFUROXIME 500MG (TAB)
06/10/2023
06/17/2023
PO
500mg
BID X 7 Days
S/P Primary LTCS; Thickly Msaf
Waiting Final Action 
06/10/2023
METRONIDAZOLE 500MG (TAB)
06/10/2023
06/17/2023
PO
500mg
TIDx7 Days
S/P LTCS; Thickly MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: